🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ann W. Silk

Dana-Farber Cancer Institute

ORCID: 0000-0003-3877-3984
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study”.

A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study

Cancer Immunology, Immunotherapy(2023)10.1007/s00262-022-03314-1
N/A
1.3DataRank · unranked
49 citations

Steven J. O’Day, Howard L. Kaufman, Jennifer Bryan, Jacqueline T. Norrell, Casey Imbergamo +17 more

High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma

Frontiers in Oncology(2020)10.3389/fonc.2019.01483
N/A
0.865DataRank · unranked
12 citations

Howard L. Kaufman, Brendan D. Curti, Janice M. Mehnert, Kim Margolin, David F. McDermott +10 more

Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications

Journal of Clinical Oncology(2024)10.1200/jco.23.02054
N/A
0.505DataRank · unranked
28 citations

Manisha Thakuria, Ann W. Silk, Daniel S. Hippe, Song Y. Park, Naomi So +19 more

Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma

Radiotherapy and Oncology(2022)10.1016/j.radonc.2022.05.012
N/A
0.406DataRank · unranked
14 citations

Michael Milligan, Jonathan D. Schoenfeld, Roy B. Tishler, Andrea K. Ng, Phillip M. Devlin +8 more

Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management

Journal of the American Academy of Dermatology(2025)10.1016/j.jaad.2025.10.032
N/A
0.269DataRank · unranked
5 citations

Manisha Thakuria, Ann W. Silk, Daniel S. Hippe, Peter Ch’en, Song Youn Park +18 more

A multicenter retrospective cohort analysis of advanced basal cell carcinoma outcomes by sex

Journal of the American Academy of Dermatology(2023)10.1016/j.jaad.2023.08.026
N/A
0DataRank · unranked
0 citations

Neha Gupta, Emily Granger, Fadi Murad, Vernon J. Forrester, Emily J. Anstadt +9 more

The prognostic value of the Merkel cell polyomavirus serum antibody test: A dual institutional observational study

Cancer(2024)10.1002/cncr.35314
N/A
0DataRank · unranked
6 citations

Sophia Z. Shalhout, Kayla M. Wright, Matt A. Miller, Howard L. Kaufman, Kevin S. Emerick +4 more

Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrence

Cancer(2024)10.1002/cncr.35507
N/A
0DataRank · unranked
2 citations

Kee‐Young Shin, Manisha Thakuria, Jonathan D. Schoenfeld, Roy B. Tishler, Ann W. Silk +4 more